PAB

PATRYS FPO [PAB]
Patrys Limited, together with its subsidiaries, develops antibody technologies for the treatment of cancer and NETosis-driven inflammatory diseases. It develops PAT-DX1, a small antibody fragment derived from a humanized version of the binding domain from the original mouse deoxymab antibody 3E10; and PAT-DX3 for treating primary and secondary brain cancers, and metastases that are associated with NETosis, or in combination with DNA damaging agents, such as radiation and other chemotherapy drugs. The company was incorporated in 2006 and is based in Nedlands, Australia.
· ASX Small Cap
$0.0360 -7.7%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when PAB triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track PAB — Free

Active Signals

Bullish Signals

  • RSI drifting toward oversold territory — worth watching
  • MACD momentum is losing steam
  • Bollinger Bands are tightening — volatility is coiling up for a potential breakout
  • Drifting lower — down 5.3% over the last 5 days
  • Low cash runway (3 quarters) - dilution risk
  • Very high P/S ratio (136.2x)
  • Revenue in sharp decline (-100%)
  • Micro-cap ($5-20M) - high risk
  • New substantial holder(s) (1)
  • Capital raise activity (1 events)
  • Sentiment is mixed — no strong consensus either way
  • The bigger volume days are the up days — volume-weighted momentum is positive (2.26%/day)
  • Altman Z-Score distress zone (1.40 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.039)
  • RBA hiking (-3pts)
  • Calendar: Quarterly 4C in 11d (+5pts)

Risk Signals

  • Trading below both moving averages — the trend is working against this one
  • Piotroski F-Score weak (3/9, low-confidence approx)
  • Not enough chatter to gauge sentiment — defaulting to neutral
  • Revenue declining at -100% — the top line is shrinking
Ask Scout AI about PAB
"What's driving PAB today?" "How does PAB compare to peers?" "Key risks for PAB?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Cleansing Notice
NONE Notification regarding unquoted securities - PAB
NONE Application for quotation of securities - PAB
HIGH Becoming a substantial holder
Announcement tone +3pts

Recent ASX Announcements

2026-07-15 Cleansing Notice
2026-07-15 Notification regarding unquoted securities - PAB
2026-07-15 Application for quotation of securities - PAB
2026-07-12 Patrys Secures 50% Revenue Share in IP Commercialisation PRICE SENSITIVE
2026-07-07 Becoming a substantial holder

Key Metrics

$13.7M
Market Cap
542K
Avg Volume
0.7x
Vol Ratio
$0.03 — $0.05
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-260.6%
ROE
N/A
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 71%
LLeader vs LaggardpassRS: 10
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral
Related Tickers
WMX +300.0%MRE +300.0%PCI +300.0%KIT +300.0%LGF +300.0%
Compare:PAB vs WMXPAB vs MREPAB vs PCI
Scout Pro — Deeper Analysis for PAB
Try Pro free for 30 days
Share this analysis

Track PAB and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required